(Q33544548)

27 July 2017

1 reference

title

Current antiarrhythmic drugs: an overview of mechanisms of action and potential clinical utility (English)

1 reference

27 July 2017

Singh BN

1

1 reference

27 July 2017

publication date

1 February 1999

1 reference

Journal of Cardiovascular Electrophysiology

27 July 2017

published in

1 reference

27 July 2017

volume

10

1 reference

27 July 2017

issue

2

1 reference

27 July 2017

page(s)

283-301

1 reference

Routine prophylactic lidocaine administration in acute myocardial infarction. An idea whose time is all but gone?

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1999.TB00674.X

A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1999.TB00674.X

The effect of amiodarone, a new anti-anginal drug, on cardiac muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1999.TB00674.X

Comparative mechanisms of action of antiarrhythmic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1999.TB00674.X

The coming of age of the class III antiarrhythmic principle: retrospective and future trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1999.TB00674.X

Antiarrhythmic drugs: a reorientation in light of recent developments in the control of disorders of rhythm

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1999.TB00674.X

Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1999.TB00674.X

Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1999.TB00674.X

Idiopathic long QT syndrome: progress and questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1999.TB00674.X

Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1999.TB00674.X

A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1999.TB00674.X

Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1999.TB00674.X

Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1999.TB00674.X

Cellular electropharmacology of amiodarone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1999.TB00674.X

Arrhythmia control by prolonging repolarization: the concept and its potential therapeutic impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1999.TB00674.X

Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1999.TB00674.X

Effectiveness of sotalol in preventing supraventricular tachyarrhythmias shortly after coronary artery bypass grafting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1999.TB00674.X

Selective versus non-selective antiarrhythmic approach for prevention of atrial fibrillation after coronary surgery: is there a need for pre-operative risk stratification? A prospective placebo-controlled study using low-dose sotalol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1999.TB00674.X

Prediction of behavioural and emotional problems in children and adolescents with operated congenital heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1999.TB00674.X

Double-blind trial of lignocaine versus sotalol for acute termination of spontaneous sustained ventricular tachycardia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1999.TB00674.X

Antiarrhythmic actions of amiodarone: a profile of a paradoxical agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1999.TB00674.X

Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Grou

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1999.TB00674.X

Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. The Intravenous Amiodarone Multicenter Investigators Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1999.TB00674.X

Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1999.TB00674.X

Channel specificity in antiarrhythmic drug action. Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1999.TB00674.X

Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1999.TB00674.X

Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1999.TB00674.X

Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1999.TB00674.X

Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1999.TB00674.X

10.1111/J.1540-8167.1999.TB00674.X

21 January 2018

Identifiers

DOI

1 reference

27 July 2017

1 reference